Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity -: The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study

被引:32
作者
Bard, JM
Charles, MA
Juhan-Vague, I
Vague, P
André, P
Safar, R
Fruchart, JC
Eschwege, E
机构
[1] Ctr Rech Nutr Humaine, UFR Pharm, Biochim Lab, F-44035 Nantes, France
[2] Ctr Rech Nutr Humaine, INSERM, U539, F-44035 Nantes, France
[3] INSERM, U21 258, Villejuif, France
[4] Hematol Lab, INSERM, CJF, Marseille, France
[5] INSERM, U337, Paris, France
[6] INSERM, U325, F-59045 Lille, France
关键词
insulin resistance syndrome; central fat distribution; triglyceride-rich lipoproteins; apolipoproteins; lipoprotein particles;
D O I
10.1161/01.ATV.21.3.407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study represents a new insight into the Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study population at inclusion. This population, selected basically on the basis of a high waist-to-hip ratio (greater than or equal to0.95 for men and greater than or equal to0.80 for women), is supposed to represent a group of patients with insulin resistance. The present study was undergone to establish whether apolipoprotein C-III (apoC-III) and apolipoprotein E (apoE) associated with apo B (apoC-III LpB and apoE LpB, respectively), considered to be markers of remnant accumulation, play a role in the hypertriglyceridemia associated with insulin resistance and whether they are related to other biological abnormalities frequently observed in this syndrome. In this population, the concentration of the markers of remnant accumulation increases with triglyceride levels. Therefore, correlation studies were realized to assess the relative effect of insulin and the markers of remnant accumulation on triglyceride plasma level, As a first attempt, a simple correlation analysis revealed that insulin is positively related to the markers of remnant accumulation only in hypertriglyceridemic patients (triglycerides greater than or equal to1.7 mmol/L), To assess the independent contribution of these markers, insulin, and other parameters related to the plasma triglyceride concentration, a stepwise multiple regression analysis was run. Results revealed that insulin and the markers of remnant accumulation (specifically, apoE LpB) are independent contributors to the plasma triglyceride concentration. Markers of the endothelial damage, plasminogen activator inhibitor-1, tissue plasminogen activator, and von Willebrand factor, which are often increased in the case of insulin resistance, were tested for their correlation with the markers of remnant accumulation. Plasminogen activator inhibitor-1 is positively correlated with these markers only in hypertriglyceridemic male subjects. It is concluded that increased insulin levels found in insulin resistance syndrome are associated with an increased production of triglyceride-rich lipoproteins enriched in apoC-III and apoE. The accumulation of these remnants and/or their abnormal composition in apoC-III and apoE could be an explanation for the development of hypertriglyceridemia in this syndrome.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 46 条
  • [41] Hyperinsulinemia and triglyceride-rich lipoproteins
    Steiner, G
    Lewis, GF
    [J]. DIABETES, 1996, 45 : S24 - S26
  • [42] SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS IS INDUCED BY VERY LOW-DENSITY-LIPOPROTEIN
    STIKORAHM, A
    WIMAN, B
    HAMSTEN, A
    NILSSON, J
    [J]. ARTERIOSCLEROSIS, 1990, 10 (06): : 1067 - 1073
  • [43] Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension
    Toft, I
    Bonaa, KH
    Ingebretsen, OC
    Nordoy, A
    Birkeland, KI
    Jenssen, T
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) : 553 - 559
  • [44] MODULATION OF LIPOPROTEIN-LIPASE ACTIVITY BY APOLIPOPROTEINS - EFFECT OF APOLIPOPROTEIN-C-III
    WANG, CS
    MCCONATHY, WJ
    KLOER, HU
    ALAUPOVIC, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (02) : 384 - 390
  • [45] WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249
  • [46] World Health Organization, 1985, DEF DIAGN CLASS DIAB, P9